MYndspan, a pioneer in consumer brain health technology, and BIOS Health, a leader in real-time neural data analysis and dosing, today announced a partnership to scale the reach and impact of precision neuroscience. By combining MYndspan’s Magnetoencephalography (MEG) powered brain scans with BIOS Health’s proprietary neural data and AI platform, […]
admin
Jan Marini Skin Research & Restore Hyper Wellness Announce New Partnership
Restore Hyper Wellness, a leader in proactive health and wellness services with over 220 studios across 40 states, is proud to announce a new partnership with Jan Marini Skin Research, Inc. (JMSR), a leading provider of professional skincare and aesthetic solutions. This collaboration enhances Restore’s Skin Health services, offering innovative, […]
Rentschler Biopharma announces strategic realignment of its global business operations
Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, announced today a realignment of its global business operations as part of a long-term strategic shift. As part of this realignment, Rentschler Biopharma will withdraw from the field of cell and gene therapy, ceasing operations at […]
MemorialCare Long Beach Medical Center Becomes First in California to Adopt Stryker’s New Q Guidance System with Spine Guidance Software
MemorialCare Long Beach Medical Center is the first in the California to adopt Stryker’s Q Guidance System with Spine Guidance Software. This system revolutionizes spinal surgery by enabling precise, computer-assisted navigation for both open and minimally invasive spine procedures. By integrating optical tracking capabilities, sophisticated algorithms, and advanced instrumentation, the […]
BayCare Pilots AI-Assisted Voice Technology for Nurses
Hoping to ease the burden of nurses at the bedside, BayCare Health System is now piloting artificial-intelligence-assisted voice technology to transform the way nurses carry out clinical documentation. The project, launched last month with a team at St. Anthony’s Hospital in St. Petersburg, aims to transform how nurses document clinical […]
Ryght AI and Cancer Research SA (CRSA) Partner to Enhance Cancer Clinical Trials in South Australia
Ryght AI, a leading provider of real-time generative AI solutions for the clinical research industry, and Cancer Research South Australia (CRSA), a premier cancer care provider, have announced a strategic partnership to advance cancer clinical trials in South Australia. Through this collaboration, CRSA will join the Ryght Research Network, leveraging […]
Tevogen Bio Broadens Relationship with Microsoft to Deepen Artificial Intelligence Collaboration and Develop PredicTcell Technology on Azure
Tevogen Bio Holdings Inc. a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified T-cell therapeutics for infectious diseases and cancers, announced today that it has broadened its relationship with Microsoft (Nasdaq: MSFT) to broaden its AI-focused collaboration and build its PredicTcell technology. PredicTcell is Tevogen Bio’s proprietary technology designed for […]
Raintree Systems Acquires Rehab Therapy AI Technology Leader Yoomi Health
Raintree announced today that it has acquired Yoomi Health, a New York-based leader in AI technologies for rehab therapy organizations. This critical addition to Raintree’s product stack will significantly accelerate the Artificial Intelligence and Machine Learning roadmap for Raintree clients. In addition to a series of strategic investments made over […]
TAHO Pharmaceuticals Completes Pivotal Trial of TAH3311, the First Oral Dissolving Film Anticoagulant
TAHO Pharmaceuticals is pleased to announce the successful completion of the pivotal trial for TAH3311, the first anticoagulant oral dissolving film (ODF). This trial was conducted following detailed discussions and alignment with the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA), marking a major milestone in the […]
YolTech Therapeutics to Initiate a Clinical Trial for YOLT-204, a First-in-Class Bone Marrow-Targeted In Vivo Gene Editing Therapy for β-Thalassemia
YolTech Therapeutics, a clinical-stage gene editing company dedicated to delivering lifelong cures, announced the initiation of a clinical trial for YOLT-204, an investigational therapy for the treatment of transfusion-dependent beta-thalassemia (TDT). TDT is a severe genetic blood disorder where mutations in the beta-globin gene leads to reduced or absence of […]
